Wei-bo Xia MD

Dr.Xia is interested in bone and mineral disease. He did the study on epidemiological trends of osteoporosis and osteoporotic fracture in China. He conducted many new agents evaluation on osteoporosis in clinical trials. To better understand the pathophysiology of osteoporosis, He carried out some genetic studies in Chinese osteoporotic populations. His research also focused on other metabolic diseases, such as the rickets and osteomalacia, especially on hypophosphatemic rickets, tumor induced osteomalacia, vitamin D deficient rickets and vitamin D dependent rickets. Hypoparathyroidism and hyperparathyroidism are also involved in his research fields. As a co-editor-in-chief, he conducted “The Chinese Guideline of Primary Hyperparathyroidism” in 2014. As author or Co-author, he has published over 200 scientific papers, including more than 60 SCI papers.